2025 ACP Internal Medicine Board Review Course Recordings

Board Prep Course Recordings

Ensure you're board-exam ready with ACP's 2025 Internal Medicine Board Review Course Recordings—a multimedia, self-study program that delivers multiple study tools for you to review and reinforce the content likely to be questioned on the exams.

View lectures in any order and as often as you like to solidify your knowledge. These on-demand multimedia sessions include 36+ hours of content and more than 250 board-style questions. ACP’s Board Review Course Recordings Package breaks the lectures into targeted, short single-question segments, so you can create a custom study schedule.

Copyright 2025 American College of Physicians. All Rights Reserved.

CME/MOC:

Up to 36 AMA PRA Category 1 Credits ™ and MOC Points
Expires September 03, 2027   active

Cost:

Discounted to Members

Format:

Interactive Multi-Media

Product:

Board Prep Course Recordings

ACP's board prep recordings are ideal for those who enjoy watching lectures at their own pace. Videos were recorded live from ACP’s Internal Medicine Board Review Course or MOC Exam Prep Course. Combining live courses and the course recordings are an effective option for a blended learning approach. Stream the sessions to your device or download for offline study.

The individuals listed below have relevant financial relationships with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No other individuals in control of content for this activity have any relevant financial relationships to disclose. All relevant financial relationships have been mitigated.

Rashmi Chugh, MD

  • Grant/Contract: Springworks, GlaxoSmithKline LLC, PharmaMar, Cogent Therapeutics LLC, Cornerstong Pharmaceuticals, Mundipharma, Polaris Pharmaceuticals, Kronos Bio, Pfizer Inc, Plexxikon Inc, Janssen Biotech, Qilu Puget Sound, AstraZeneca Pharmaceuticals LP, Astex Pharmaceuticals, Ayala, PTC Therapeutics Inc, Epizyme Inc.
  • Consultant: Jazz Pharmaceuticals, Deciphera Pharmaceuticals, Inhibrx Inc.

Laura Mariani, MD, MS

  • Grant/Contract: Boehringer Ingelheim, Reliant Glycosciences
  • Consultant: Vera Therapeutics, Novartis Pharma AG, Chinook Therapeutics, Dimerix Limited, Travere Therapeutics Inc.
  • Speaker: Otsuka Pharmaceutical Co. Ltd.

Dejan Micic, MD

  • Consultant: Takeda Pharmaceutical Company, Ironwood Pharmaceuticals Inc.

Frank Wang, MD

  • Grant/Contract: Galderma Laboratories LP, ET Browne Company, AbbVie